Actavis Launch Atorvastatin In Spain

Actavis has announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. The product, Atorvastatin Magnesium, is launched by four of Spain’s largest generic pharmaceutical companies. Distribution of the product to Spanish pharmacies has already started.

Atorvastatin efficiently regulates the blood cholesterol levels and is used for the treatment of primary hypercholesterolemia. Atorvastatin Magnesium is produced by Actavis in 10mg, 20mg and 40mg tablets. Pfizer, the originator, markets its product in Spain under the brand names of Cardyl and Zarator. Atorvastatin’s US brand name is Lipitor.

Medis is currently promoting three different dossiers for Atorvastatin and has been supplying a product suitable for Central Eastern Europe for close to two years. Medis’ alternative generic, Atorvastatin Magnesium, has been approved by the Spanish authorities.

Actavis has already launched Atorvastatin Calcium under its own brand name in 15 countries in Europe and Asia where there was no patent. Atorvastatin Magnesium will be launched in Spain under Actavis’ own brand name shortly.